TransMedics Group’s (TMDX) “Overweight” Rating Reiterated at Piper Sandler

Piper Sandler reissued their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a report released on Friday morning,Benzinga reports. Piper Sandler currently has a $125.00 price objective on the stock, up from their previous price…

Read Full Article →